Category Archives: Drug Resistance

Study says healthcare shortcomings leave tuberculosis undiagnosed, untreated

By on .

In a prospective autopsy study published in The Lancet of patients who died at a hospital in Lusaka, Zambia, researchers found a large percentage of patients were infected with tuberculosis but had gone undiagnosed and untreated, and 17 percent of patients infected with tuberculosis were indeed infected with multidrug-resistant TB but also remained undiagnosed. Aiming […]

Briefing speakers, report: antibiotic resistant infections “pose a catastrophic threat to people in every country”

By on .

When Rep. Gene Green (D-TX) practiced as an attorney in Texas during the 1980s, some of his clients had become infected with tuberculosis that had become resistant to the first and best line of treatment. He had to talk to them through walls to avoid exposure to the disease, he said, often having to shout […]

WHO guidance on first new TB treatment in five decades offers hope, emphasizes monitoring

By on .

WHO cites need to prevent new drug resistance, protect first treatment advance in more than 40 years The World Health Organization’s release this week of  interim policy guidelines on the use of bedaquiline  for treatment of multidrug-resistant tuberculosis  offers hope to patients and their physicians running out of options to treat the disease, but the […]

TB Week: Integration, involvement, a “holistic” approach key to linking women and tuberculosis care

By on .

When a week of events focusing on the worldwide impact of tuberculosis brings together a group to talk about women’s health and diplomacy, it needs to be a broad-based group, and it was. For a start, the talk at the Washington Club in Washington, DC was sponsored by The Center for Global Health and Diplomacy, […]

TB Week: Survivors and allies recount illness, treatment, and loss

By on .

In the week leading up to International Tuberculosis Day, which commemorates the discovery by Robert Koch of the cause of the disease in 1882, Science Speaks will look at issues, events and efforts to confront this lasting and global health threat. When South African nurse Pat Bond got sick in 2010, doctors treated her for […]

Entrepreneur uses cell phones to fight counterfeit drugs while linking patients with answers

By on .

“In healthcare we have to work with what’s already happening” Nathan Sigworth was a freshman in college when he spent a month visiting a small hospital in India, and made a simple discovery: economics there dictated a very different delivery of health care than he was used to seeing. In time, he discovered that while […]

IOM report looks at global scope of fake and substandard drugs, while study zeroes in on TB impact

By on .

The report released this morning by the Institute Of Medicine portrays a global and growing danger that is both deadly and resource draining, brings the highest risks in the poorest countries, and threatens affluent countries as well. Still, coordinated efforts to tackle the proliferation of fake and substandard medicines lag far behind other efforts to […]

CDC report on U.S. TB drug shortage reflects local and global challenges

By on .

With no medicine on hand, a father and his infant who have just been diagnosed with multidrug-resistant tuberculosis go untreated, the delay prolonging their recoveries as well as the time they will remain infectious. The delay adds to the risk that they will get sicker and resistant to more drugs, increases the odds that those […]

FDA TB drug approval a milestone, with caveats

By on .

The U.S. Food and Drug Administration’s approval of the first new drug to treat tuberculosis in nearly half a century and the agency’s first use of its accelerated approval process to speed availability of TB medicine comes with cautions, and with a direction of work yet to be done, agency officials and treatment advocates agree. […]